The management of a large Chinese pharma company started looking for a pharma API/formulations manufacturing company to buy, in order to establish a presence in Europe. The buyer would prefer a medium-scale manufacturing facility with an R&D department, laboratory, quality control and warehouse.
The buyer is one of the leading vertically integrated pharmaceutical companies in China focusing on the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished formulations. The company owns large scale manufacturing facilities for the production of chemical synthesized, lyophilized, sterile crystallized and fermented APIs.
The company is quite large, with over 1 billion EUR in revenue, and significant export to the United States. The company has multiple manufacturing sites and over 20 sales subsidiaries all around the world. The company is well known for its aggressive R&D attitude, with over 2000 people committed to research and development of new drugs.
The buyer is starting now to search for opportunities, the company had not made any acquisitions in Europe yet. However, the company is already present in Europe, with over 50 approved products on the EU market.
Contact us to get details about this buyer of pharma companies now
The buyer company is specialized in research, manufacturing and sales/marketing of pharmaceutical products. Now the management started looking for an acquisition of a pharma manufacturing company, in order to start production in Europe.
The target company should be specialized in one of the following product categories:
The target company should preferably be based in the EU, Southern or Eastern Europe. Targets from the UK will not be considered. The target company should be a manufacturer, however, it is not necessary – distributors or research companies will also be a possibility. It is required though for the target to have a laboratory of control and warehousing capacities.
The target should be financially healthy, have qualified personnel, packaging capacity. Also, it is required to meet all regulatory requirements of the EU.
The goal of the buyer is to acquire a fully regulatory compliant pharmaceutical manufacturing/distribution company under running condition.
Feel free to contact us for more information regarding this pharmaceutical manufacturer buyer in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.